| Literature DB >> 28184428 |
Karl Michaëlsson, Alicja Wolk, Håkan Melhus, Liisa Byberg.
Abstract
High milk consumption might shorten life span through increased oxidative stress. We aimed to determine whether higher mortality rates with high milk consumption are modified by fruit and vegetable intake or total antioxidant intake (oxygen radical absorbance capacity). We used information from food frequency questionnaires completed by 61,420 women in a Swedish cohort (22,391 deaths from the 1987-1990 baseline onward), 36,714 women from a second survey (1997) of this cohort, and 45,280 Swedish men (15,478 deaths from the 1998 baseline onward). Compared with low consumption of milk (<1 glass/day) and high consumption of fruits/vegetables (≥5 servings/day), time-updated information revealed an adjusted hazard ratio for death of 2.79 (95% confidence interval (CI): 2.42, 3.21) in women who consumed ≥3 glasses of milk/day and <1 serving/day of fruit/vegetables and a hazard ratio of 1.60 (95% CI: 1.40, 1.82) in women who consumed the same amount of milk but ≥5 servings/day of fruits/vegetables. The same comparisons in men, based on a single food frequency questionnaire, displayed hazard ratios of 1.31 (95% CI: 1.14, 1.51) and 1.07 (95% CI: 0.97, 1.18), respectively. Total antioxidant consumption showed similar patterns as fruit/vegetable intakes. Dietary antioxidant intake, especially in women, seems to modify the elevated death rate associated with high milk consumption.Entities:
Keywords: antioxidants; fruit; galactose; lactose; milk; mortality; oxidative stress; vegetables
Mesh:
Substances:
Year: 2017 PMID: 28184428 PMCID: PMC5391717 DOI: 10.1093/aje/kww124
Source DB: PubMed Journal: Am J Epidemiol ISSN: 0002-9262 Impact factor: 4.897
Characteristics of the Swedish Mammography Cohort (Women) According to Milk Consumption at the 1987–1990 Baseline (n = 61,240)
| Characteristic | Milk Intake, glasses/day | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| <1 | 1–<2 | 2–<3 | ≥3 | |||||||||
| Mean (SD) | No. of Persons | % | Mean (SD) | No. of Persons | % | Mean (SD) | No. of Persons | % | Mean (SD) | No. of Persons | % | |
| All participants | 16,869 | 27.5 | 23,385 | 38.2 | 15,405 | 25.2 | 5,581 | 9.1 | ||||
| Age at entry, years | 53.2 (9.5) | 54.0 (9.7) | 54.1 (9.9) | 52.8 (9.6) | ||||||||
| Body mass index[ | 24.4 (3.9) | 24.7 (3.8) | 25.0 (4.0) | 24.9 (4.2) | ||||||||
| Height, m ( | 1.64 (0.06) | 1.64 (0.06) | 1.64 (0.06) | 1.64 (0.06) | ||||||||
| Dietary intake | ||||||||||||
| Energy, kcal/day | 1,414 (433) | 1,537 (413) | 1,709 (433) | 1,967 (525) | ||||||||
| Milk, g/day[ | 17.3 (37.3) | 201.6 (14.9) | 400.2 (6.0) | 676.8 (151.9) | ||||||||
| Yogurt, g/day | 102.7 (117.3) | 97.8 (101.2) | 93.4 (105.1) | 87.2 (113.1) | ||||||||
| Cheese, g/day | 26.8 (21.2) | 26.3 (19.6) | 26.8 (19.8) | 27.7 (22.0) | ||||||||
| Fruit, g/day ( | 201.0 (143.4) | 196.6 (132.5) | 191.6 (136.7) | 183.0 (147.1) | ||||||||
| Vegetables, g/day ( | 92.5 (67.5) | 87.6 (60.2) | 85.7 (63.8) | 81.7 (63.9) | ||||||||
| Fruit and vegetables, servings/day | 3.6 (2.1) | 3.5 (1.9) | 3.4 (2.0) | 3.2 (2.1) | ||||||||
| Red and processed meat, g/day | 70.2 (42.2) | 75.5 (39.8) | 79.8 (40.6) | 85.4 (44.8) | ||||||||
| Protein, g/day | 62.3 (9.1) | 66.4 (8.0) | 69.9 (8.2) | 73.1 (8.8) | ||||||||
| Total fat, g/day | 44.3 (17.0) | 48.9 (16.7) | 55.0 (18.4) | 65.0 (24.2) | ||||||||
| Saturated fat, g/day | 19.0 (8.1) | 21.4 (8.0) | 24.5 (9.1) | 30.0 (12.6) | ||||||||
| Calcium, mg/day | 733 (159) | 859 (139) | 972 (144) | 1,101 (174) | ||||||||
| Vitamin D, μg/day | 3.9 (1.3) | 4.4 (1.2) | 4.8 (1.4) | 5.1 (1.7) | ||||||||
| Phosphorus, mg/day | 1,242 (184) | 1,365 (165) | 1,478 (174) | 1,587 (204) | ||||||||
| Retinol, mg/day | 0.94 (0.70) | 1.03 (0.64) | 1.09 (0.61) | 1.09 (0.59) | ||||||||
| Alcohol, g/day | 3.1 (4.0) | 2.6 (3.5) | 2.1 (3.0) | 1.9 (3.0) | ||||||||
| Physical activity, MET-hours/day[ | 42.2 (4.8) | 42.4 (4.8) | 42.6 (4.8) | 42.8 (5.0) | ||||||||
| Leisure-time physical activity, hours/week[ | ||||||||||||
| <1 | 3,256 | 19.3 | 4,396 | 18.8 | 2,900 | 18.8 | 1,077 | 19.3 | ||||
| 1 | 4,254 | 25.2 | 6,094 | 26.1 | 3,954 | 25.7 | 1,429 | 25.6 | ||||
| 2–3 | 5,282 | 31.3 | 7,526 | 32.2 | 4,900 | 31.8 | 1,783 | 31.9 | ||||
| 4–5 | 2,423 | 14.4 | 3,286 | 14.1 | 2,301 | 14.9 | 783 | 14.0 | ||||
| >5 | 1,654 | 9.8 | 2,083 | 8.9 | 1,350 | 8.8 | 509 | 9.1 | ||||
| Education, years | ||||||||||||
| ≤9 | 13,235 | 78.5 | 18,676 | 79.9 | 12,487 | 81.1 | 4,393 | 78.7 | ||||
| 10–12 | 1,366 | 8.1 | 1,699 | 7.3 | 1,054 | 6.8 | 403 | 7.2 | ||||
| >12 | 897 | 5.3 | 1,146 | 4.9 | 632 | 4.1 | 266 | 4.8 | ||||
| Other[ | 1,371 | 8.1 | 1,864 | 8.0 | 1,232 | 8.0 | 519 | 9.3 | ||||
| Smoking status[ | ||||||||||||
| Never smoker | 8,206 | 48.6 | 12,221 | 52.3 | 7,870 | 51.1 | 2,595 | 46.5 | ||||
| Former smoker | 5,318 | 31.5 | 6,875 | 29.4 | 4,450 | 28.9 | 1,646 | 29.5 | ||||
| Current smoker | 3,345 | 19.8 | 4,289 | 18.3 | 3,085 | 20.0 | 1,340 | 24.0 | ||||
| Living alone | 3,939 | 23.4 | 5,292 | 22.6 | 3,741 | 24.3 | 1,430 | 25.6 | ||||
| Charlson comorbidity index[ | ||||||||||||
| 0 | 15,143 | 89.8 | 21,111 | 90.3 | 13,817 | 89.7 | 4,907 | 87.9 | ||||
| 1 | 1,401 | 8.3 | 1,791 | 7.7 | 1,231 | 8.0 | 528 | 9.5 | ||||
| ≥2 | 325 | 1.9 | 483 | 2.1 | 357 | 2.3 | 146 | 2.6 | ||||
| Current use of calcium-containing supplements (regular or occasional)[ | 2,914 | 17.3 | 3,840 | 16.4 | 2,159 | 14.0 | 801 | 14.4 | ||||
| Ever use of antioxidant-containing supplements[ | 5,027 | 29.8 | 6,700 | 28.7 | 3,895 | 25.3 | 1,348 | 24.2 | ||||
| Ever use of estrogen replacement therapy[ | 3,495 | 20.7 | 5,063 | 21.7 | 3,508 | 22.8 | 1,458 | 26.1 | ||||
| Ever use of cortisone[ | 897 | 5.3 | 1,057 | 4.5 | 733 | 4.8 | 256 | 4.6 | ||||
Abbreviations: MET, metabolic equivalent; SD, standard deviation.
a Weight (kg)/height (m)2.
b 1 g/day of milk ≈ 1 mL/day.
c Values were imputed from the 1997 questionnaire.
d Such as vocational education.
eInternational Classification of Diseases (Eighth, Ninth, and Tenth revisions) diagnosis codes were collated from the National Patient Registry to calculate weighted Charlson comorbidity scores. The Charlson comorbidity index predicts mortality for a patient who may have a range of up to 17 comorbid conditions. Each condition is assigned a score of 1–6, depending on the risk of dying associated with the condition.
Characteristics of the Cohort of Swedish Men (Men) According to Milk Consumption at the 1997 Baseline (n = 45,280)
| Characteristic | Milk Intake, glasses/day | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| <1 | 1–<2 | 2–<3 | ≥3 | |||||||||
| Mean (SD) | No. of Persons | % | Mean (SD) | No. of Persons | % | Mean (SD) | No. of Persons | % | Mean (SD) | No. of Persons | % | |
| All participants | 20,144 | 44.5 | 10,803 | 23.9 | 7,459 | 16.5 | 6,874 | 15.2 | ||||
| Age at entry, years | 59.5 (9.6) | 61.2 (9.9) | 61.1 (9.8) | 60.1 (9.5) | ||||||||
| Body mass index[ | 25.6 (3.2) | 25.6 (3.3) | 25.9 (3.4) | 26.4 (3.6) | ||||||||
| Height, m ( | 1.77 (0.07) | 1.77 (0.07) | 1.77 (0.07) | 1.77 (0.07) | ||||||||
| Dietary intake | ||||||||||||
| Energy, kcal/day | 2,511 (789) | 2,583 (772) | 2,749 (798) | 3,129 (914) | ||||||||
| Milk, g/day[ | 64.7 (68.3) | 267.5 (59.4) | 467.3 (49.3) | 909.1 (372.4) | ||||||||
| Yogurt, g/day | 181.4 (237.6) | 165.7 (222.1) | 177.9 (245.2) | 185.6 (286.8) | ||||||||
| Cheese, g/day | 72.8 (59.8) | 70.6 (54.9) | 75.0 (57.7) | 85.8 (66.1) | ||||||||
| Fruit, g/day ( | 182.1 (140.6) | 182.5 (133.0) | 173.8 (137.3) | 162.1 (131.3) | ||||||||
| Vegetables, g/day ( | 184.2 (125.0) | 181.2 (123.6) | 173.0 (118.3) | 163.5 (118.7) | ||||||||
| Fruit and vegetables, servings/day | 4.2 (2.5) | 4.2 (2.4) | 3.9 (2.4) | 3.7 (2.3) | ||||||||
| Oxygen radical absorbance capacity, µmol/day | 14,218 (5,376) | 14,740 (5,354) | 14,834 (5,563) | 15,153 (5,708) | ||||||||
| Red and processed meat, g/day | 101.9 (63.8) | 102.3 (63.8) | 103.3 (59.2) | 108.8 (61.4) | ||||||||
| Protein, g/day | 98.3 (14.7) | 102.1 (13.9) | 105.4 (14.0) | 111.3 (15.1) | ||||||||
| Total fat, g/day | 89.6 (15.5) | 89.3 (14.6) | 89.2 (14.9) | 89.0 (15.6) | ||||||||
| Saturated fat, g/day | 40.3 (9.5) | 40.6 (9.1) | 41.2 (9.5) | 42.0 (10.0) | ||||||||
| Calcium, mg/day | 1,247 (386) | 1,450 (370) | 1,640 (386) | 1,945 (483) | ||||||||
| Vitamin D, μg/day | 6.1 (3.0) | 6.7 (2.9) | 7.0 (2.9) | 7.7 (3.0) | ||||||||
| Phosphorus, mg/day | 1,922 (294) | 2,063 (282) | 2,185 (292) | 2,387 (350) | ||||||||
| Retinol, mg/day | 1.19 (0.96) | 1.25 (0.85) | 1.28 (0.71) | 1.35 (0.74) | ||||||||
| Alcohol, g/day ( | 17.0 (22.9) | 13.7 (17.6) | 13.1 (18.7) | 14.2 (26.8) | ||||||||
| Physical activity, MET-hours/day ( | 41.2 (4.8) | 41.5 (4.8) | 41.8 (5.0) | 42.3 (5.3) | ||||||||
| Leisure-time physical activity, hours/week ( | ||||||||||||
| <1 | 3,988 | 22.1 | 1,940 | 20.0 | 1,452 | 21.7 | 1,488 | 24.6 | ||||
| 1 | 3,470 | 19.2 | 1,845 | 19.0 | 1,295 | 19.4 | 1,078 | 17.9 | ||||
| 2–3 | 5,691 | 31.5 | 3,127 | 32.2 | 2,064 | 30.9 | 1,792 | 29.7 | ||||
| 4–5 | 2,315 | 12.8 | 1,256 | 12.9 | 876 | 13.1 | 728 | 12.1 | ||||
| >5 | 2,592 | 14.4 | 1,547 | 15.9 | 999 | 14.9 | 953 | 15.8 | ||||
| Education, years ( | ||||||||||||
| ≤9 | 13,072 | 65.1 | 7,437 | 69.0 | 5,502 | 74.1 | 5,308 | 77.5 | ||||
| 10–12 | 3,151 | 15.7 | 1,526 | 14.2 | 884 | 11.9 | 710 | 10.4 | ||||
| >12 | 3,775 | 18.8 | 1,764 | 16.4 | 1,021 | 13.7 | 800 | 11.7 | ||||
| Other[ | 80 | 0.4 | 46 | 0.4 | 23 | 0.3 | 30 | 0.4 | ||||
| Smoking status ( | ||||||||||||
| Never smoker | 6,996 | 35.0 | 4,152 | 38.7 | 2,718 | 36.9 | 2,301 | 33.8 | ||||
| Former smoker | 8,191 | 41.0 | 4,028 | 37.6 | 2,694 | 36.6 | 2,488 | 36.6 | ||||
| <20 pack-years[ | 4,884 | 25.8 | 2,381 | 23.6 | 1,535 | 22.3 | 1,337 | 21.0 | ||||
| ≥20 pack-years | 2,656 | 14.1 | 1,277 | 12.6 | 895 | 13.0 | 900 | 14.1 | ||||
| Current smoker | 4,786 | 24.0 | 2,539 | 23.7 | 1,954 | 26.5 | 2,011 | 29.6 | ||||
| <20 pack-years | 1,763 | 9.3 | 933 | 9.2 | 712 | 10.3 | 653 | 10.2 | ||||
| ≥20 pack-years | 2,599 | 13.8 | 1,352 | 13.4 | 1,027 | 14.9 | 1,188 | 18.6 | ||||
| Living alone | 3,317 | 16.5 | 1,831 | 16.9 | 1,311 | 17.6 | 1,376 | 20.0 | ||||
| Charlson comorbidity index[ | ||||||||||||
| 0 | 17,102 | 84.9 | 8,892 | 82.3 | 6,182 | 82.9 | 5,667 | 82.4 | ||||
| 1 | 2,152 | 10.7 | 1,314 | 12.2 | 883 | 11.8 | 838 | 12.2 | ||||
| ≥2 | 890 | 4.4 | 597 | 5.5 | 394 | 5.3 | 369 | 5.4 | ||||
| Current use of calcium-containing supplements (regular or occasional) | 2,912 | 14.5 | 1,526 | 14.1 | 976 | 13.1 | 837 | 12.2 | ||||
| Ever use of antioxidant-containing supplements | 6,395 | 31.7 | 3,380 | 31.3 | 2,250 | 30.2 | 1,978 | 28.8 | ||||
| Ever use of aspirin | 6,500 | 32.3 | 3,585 | 33.2 | 2,397 | 32.1 | 2,255 | 32.8 | ||||
| Ever hypercholesterolemia[ | 8,967 | 44.5 | 4,704 | 43.5 | 3,221 | 43.2 | 3,145 | 45.8 | ||||
| Ever use of cortisone | 843 | 4.2 | 449 | 4.2 | 309 | 4.1 | 310 | 4.5 | ||||
Abbreviations: MET, metabolic equivalent; SD, standard deviation.
a Weight (kg)/height (m)2.
b 1 g/day of milk ≈ 1 mL/day.
c Such as vocational education.
d Information on pack-years of smoking was available for 42,259 participants.
eInternational Classification of Diseases (Eighth, Ninth, and Tenth revisions) diagnosis codes were collated from the National Patient Registry to calculate weighted Charlson comorbidity scores. The Charlson comorbidity index predicts mortality for a patient who may have a range of up to 17 comorbid conditions. Each condition is assigned a score of 1–6, depending on the risk of dying associated with the condition.
f High cholesterol or ever use of statins.
Characteristics of the Swedish Mammography Cohort (Women) According to Milk Consumption at the 1997 Baseline (n = 36,714)
| Characteristic | Milk Intake, glasses/day | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| <1 | 1–<2 | 2<3 | 3 | |||||||||
| Mean (SD) | No. of Persons | % | Mean (SD) | No. of Persons | % | Mean (SD) | No. of Persons | % | Mean (SD) | No. of Persons | % | |
| All participants | 26,617 | 72.5 | 7,282 | 19.8 | 2,157 | 5.9 | 658 | 1.8 | ||||
| Age at entry, years | 61.2 (9.2) | 63.4 (9.3) | 63.2 (9.1) | 63.0 (9.5) | ||||||||
| Body mass index[ | 24.9 (3.9) | 25.4 (4.0) | 25.6 (4.2) | 25.4 (4.1) | ||||||||
| Height, m ( | 1.65 (0.06) | 1.64 (0.06) | 1.65 (0.06) | 1.65 (0.06) | ||||||||
| Dietary intake | ||||||||||||
| Energy, kcal/day | 1,676 (504) | 1,827 (521) | 2,005 (561) | 2,271 (651) | ||||||||
| Milk, g/day[ | 75.6 (60.6) | 277.2 (34.4) | 465.0 (65.1) | 908.7 (307.8) | ||||||||
| Yogurt, g/day | 173.7 (194.8) | 182.1 (209.4) | 195.3 (250.0) | 276.3 (409.6) | ||||||||
| Cheese, g/day | 49.3 (40.0) | 50.4 (37.6) | 55.6 (42.5) | 59.6 (51.8) | ||||||||
| Fruit, g/day ( | 227.8 (155.3) | 218.7 (152.8) | 209.9 (149.9) | 223.9 (176.2) | ||||||||
| Vegetables, g/day ( | 219.4 (144.8) | 211.6 (141.0) | 208.4 (135.2) | 213.5 (148.6) | ||||||||
| Fruit and vegetables, servings/day | 5.4 (3.0) | 5.1 (2.9) | 5.0 (2.8) | 5.2 (3.1) | ||||||||
| Oxygen radical absorbance capacity, µmol/day | 12,841 (5,030) | 13,225 (5,254) | 13,374 (5,106) | 13,803 (5,865) | ||||||||
| Red and processed meat, g/day | 63.8 (45.0) | 67.7 (46.1) | 70.8 (50.4) | 68.3 (51.0) | ||||||||
| Protein, g/day | 69.5 (11.4) | 72.8 (11.0) | 75.3 (11.2) | 81.2 (11.9) | ||||||||
| Total fat, g/day | 60.1 (10.4) | 59.1 (9.8) | 58.5 (10.2) | 56.2 (10.8) | ||||||||
| Saturated fat, g/day | 27.3 (6.4) | 27.1 (6.1) | 27.1 (6.3) | 26.9 (6.6) | ||||||||
| Calcium, mg/day | 977 (270) | 1,157 (268) | 1,297 (288) | 1,618 (383) | ||||||||
| Vitamin D, μg/day | 4.3 (1.6) | 4.9 (1.5) | 5.4 (1.5) | 6.0 (1.8) | ||||||||
| Phosphorus, μg/day | 1,356 (211) | 1,488 (210) | 1,581 (219) | 1,800 (280) | ||||||||
| Retinol, mg/day | 0.86 (0.68) | 0.95 (0.73) | 0.98 (0.73) | 1.00 (0.49) | ||||||||
| Alcohol, g/day | 4.5 (5.4) | 3.2 (4.5) | 2.9 (4.3) | 3.8 (7.2) | ||||||||
| Physical activity, MET-hours/day ( | 42.3 (4.7) | 42.8 (4.8) | 42.6 (5.0) | 42.7 (5.4) | ||||||||
| Leisure-time physical activity, hours/week ( | ||||||||||||
| <1 | 4,687 | 19.6 | 1,285 | 19.8 | 375 | 19.8 | 118 | 21.0 | ||||
| 1 | 5,729 | 24.0 | 1,469 | 22.7 | 428 | 22.6 | 116 | 20.7 | ||||
| 2–3 | 8,045 | 33.7 | 2,220 | 34.3 | 635 | 33.5 | 170 | 30.3 | ||||
| 4–5 | 2,773 | 11.6 | 797 | 12.3 | 228 | 12.0 | 71 | 12.7 | ||||
| >5 | 2,633 | 11.0 | 703 | 10.9 | 231 | 12.2 | 86 | 15.3 | ||||
| Education, years ( | ||||||||||||
| ≤9 | 19,126 | 71.9 | 5,759 | 79.2 | 1,721 | 79.8 | 483 | 73.4 | ||||
| 10–12 | 2,133 | 8.0 | 465 | 6.4 | 115 | 5.3 | 50 | 7.6 | ||||
| >12 | 5,294 | 19.9 | 1,035 | 14.2 | 311 | 14.4 | 123 | 18.7 | ||||
| Other[ | 40 | 0.2 | 16 | 0.2 | 10 | 0.5 | 2 | 0.3 | ||||
| Smoking status ( | ||||||||||||
| Never smoker | 13,804 | 52.7 | 4,134 | 57.6 | 1,157 | 54.2 | 333 | 51.2 | ||||
| Former smoker | 6,348 | 24.2 | 1,384 | 19.3 | 395 | 18.5 | 150 | 23.0 | ||||
| <20 pack-years[ | 4,910 | 19.2 | 1,038 | 14.8 | 277 | 13.3 | 115 | 18.1 | ||||
| ≥20 pack-years | 1,069 | 4.2 | 255 | 3.6 | 81 | 3.9 | 26 | 4.1 | ||||
| Current smoker | 6,064 | 23.1 | 1,662 | 23.1 | 583 | 27.3 | 168 | 25.8 | ||||
| <20 pack-years | 3,328 | 13.0 | 886 | 12.6 | 297 | 14.3 | 74 | 11.7 | ||||
| ≥20 pack-years | 2,460 | 9.6 | 700 | 10.0 | 268 | 12.9 | 86 | 13.6 | ||||
| Living alone | 5,580 | 21.0 | 1,691 | 23.2 | 504 | 23.4 | 172 | 26.1 | ||||
| Charlson comorbidity index[ | ||||||||||||
| 0 | 23,416 | 88.0 | 6,290 | 86.4 | 1,857 | 86.1 | 541 | 82.2 | ||||
| 1 | 2,163 | 8.1 | 668 | 9.2 | 219 | 10.2 | 74 | 11.2 | ||||
| ≥2 | 1,038 | 3.9 | 324 | 4.4 | 81 | 3.8 | 43 | 6.5 | ||||
| Current use of calcium-containing supplements (regular or occasional) | 6,465 | 24.3 | 1,735 | 23.8 | 529 | 24.5 | 160 | 24.3 | ||||
| Ever use of antioxidant-containing supplements | 11,764 | 44.2 | 3,174 | 43.6 | 930 | 43.1 | 288 | 43.8 | ||||
| Ever use of aspirin | 11,495 | 43.2 | 3,132 | 43.0 | 960 | 44.5 | 285 | 43.3 | ||||
| Ever hypercholesterolemia[ | 9,520 | 35.8 | 2,699 | 37.1 | 771 | 35.7 | 216 | 32.8 | ||||
| Ever use of estrogen replacement therapy | 12,440 | 47.5 | 3,115 | 43.5 | 906 | 42.7 | 313 | 48.5 | ||||
| Ever use of cortisone | 1,929 | 7.2 | 550 | 7.6 | 196 | 9.1 | 52 | 7.9 | ||||
Abbreviations: MET, metabolic equivalent; SD, standard deviation.
a Weight (kg)/height (m)2.
b 1 g/day of milk ≈ 1 mL/day.
c Such as vocational education.
d Information on pack-years of smoking was available for 35,298 participants.
eInternational Classification of Diseases (Eighth, Ninth, and Tenth revisions) diagnosis codes were collated from the National Patient Registry to calculate weighted Charlson comorbidity scores. The Charlson comorbidity index predicts mortality for a patient who may have a range of up to 17 comorbid conditions. Each condition is assigned a score of 1–6, depending on the risk of dying associated with the condition.
f High cholesterol or ever use of statins.
Figure 1.Sex-specific multivariable-adjusted spline curves illustrating the relationship of milk intake (A), fruit and vegetable intake (B), and oxygen radical absorbance capacity (ORAC; µmol/day) (C) with hazard ratios for death from all causes by the use of time-updated information in the whole Swedish Mammography Cohort (SMC; baseline 1987–1990) (solid line), in the SMC after administration of the second food frequency questionnaire (baseline 1997) (short-dashed line), and in the Cohort of Swedish Men (baseline 1998) (long-dashed line). The shaded areas illustrate 95% confidence intervals. One glass of milk corresponds to 200 mL. Covariates were age, body mass index (weight (kg)/height (m)2), height, energy intake, alcohol intake, intakes of yogurt, cheese, and red and processed meat, education, marital status (living alone vs. not), physical activity (metabolic equivalent-hours/day), smoking habits (never, former, or current smoker and, for baseline 1997, also pack-years of smoking), ever use of antioxidant-containing supplements, and weighted Charlson's comorbidity index. Associations with milk intake were further adjusted for intake of fruit and vegetables, and associations with fruit and vegetable intake and ORAC were adjusted for intake of milk.
Age-Standardized Rates of Mortality in the Swedish Mammography Cohort (Women) and the Cohort of Swedish Men (Men) per 1,000 Person-Years at Risk, According to Milk Consumption, Fruit and Vegetable Intake, and Quartile of Oxygen Radical Absorbance Capacity, 1987–2015[a]
| Milk Intake, glasses/day | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| <1 | 1–<2 | 2–<3 | ≥3 | |||||||||||||||||
| Mortality Rate | 95% CI | No. of Cases | PY at Risk | Total No.[ | Mortality Rate | 95% CI | No. of Cases | PY at Risk | Total No. | Mortality Rate | 95% CI | No. of Cases | PY at Risk | Total No. | Mortality Rate | 95% CI | No. of Cases | PY at Risk | Total No. | |
| Fruit/vegetable intake, servings/day | ||||||||||||||||||||
| <1 | 22.5 | 20.3, 24.8 | 416 | 16,627 | 23.3 | 21.3, 25.4 | 509 | 20,458 | 28.6 | 25.8, 31.7 | 423 | 15,336 | 27.1 | 23.3, 31.5 | 213 | 8,424 | ||||
| 1–<2 | 17.1 | 16.1, 18.2 | 971 | 53,107 | 19.6 | 18.5, 20.7 | 1,264 | 62,158 | 19.8 | 18.3, 21.3 | 776 | 42,498 | 21.5 | 19.1, 24.2 | 310 | 17,065 | ||||
| 2–<5 | 14.1 | 13.7, 14.5 | 4,116 | 283,776 | 15.5 | 15.0, 15.9 | 4,389 | 282,627 | 17.6 | 16.9, 18.4 | 2,257 | 143,057 | 19.4 | 17.9, 21.0 | 734 | 47,815 | ||||
| ≥5 | 12.1 | 11.7, 12.6 | 2,786 | 218,644 | 13.3 | 12.8, 13.9 | 2,168 | 149,108 | 15.1 | 14.1, 16.2 | 812 | 56,873 | 17.1 | 15.0, 19.4 | 247 | 16,597 | ||||
| Fruit/vegetable intake, servings/day | ||||||||||||||||||||
| <1 | 27.7 | 23.8, 32.1 | 219 | 413 | 32.5 | 25.5, 40.7 | 92 | 160 | 41.8 | 28.0, 60.0 | 29 | 52 | 40.2 | 19.9, 72.0 | 12 | 20 | ||||
| 1–<2 | 21.9 | 20.1, 23.7 | 624 | 1,541 | 23.8 | 20.8, 27.2 | 240 | 528 | 21.6 | 16.6, 27.6 | 66 | 171 | 29.3 | 18.9, 43.6 | 29 | 51 | ||||
| 2–<5 | 18.2 | 17.6, 18.8 | 3,277 | 11,827 | 18.8 | 17.7, 20.0 | 1,124 | 3,325 | 21.5 | 19.3, 23.8 | 373 | 1,025 | 23.6 | 19.4, 28.4 | 113 | 296 | ||||
| ≥5 | 16.0 | 15.4, 16.7 | 2,827 | 12,836 | 17.4 | 16.3, 18.6 | 926 | 3,269 | 18.8 | 16.7, 21.2 | 284 | 909 | 18.0 | 14.2, 22.5 | 79 | 291 | ||||
| Fruit/vegetable intake, servings/day | ||||||||||||||||||||
| <1 | 32.8 | 29.6, 36.3 | 383 | 774 | 32.2 | 27.9, 37.1 | 227 | 399 | 32.6 | 27.8, 38.0 | 191 | 331 | 32.5 | 28.4, 37.1 | 228 | 457 | ||||
| 1–<2 | 25.7 | 24.1, 27.5 | 890 | 2,354 | 26.4 | 24.2, 28.7 | 571 | 1,300 | 28.3 | 25.8, 30.9 | 488 | 1,097 | 26.5 | 24.1, 29.2 | 438 | 1,133 | ||||
| 2–<5 | 21.4 | 20.7, 22.2 | 3,291 | 10,889 | 22.4 | 21.4, 23.4 | 2,087 | 5,979 | 23.2 | 22.0, 24.4 | 1,434 | 4,100 | 24.6 | 23.3, 26.0 | 1,312 | 3,773 | ||||
| ≥5 | 20.2 | 19.3, 21.2 | 1,754 | 6,127 | 21.7 | 20.4, 23.0 | 1,030 | 3,125 | 21.4 | 19.7, 23.1 | 634 | 1,931 | 22.9 | 21.0, 24.9 | 520 | 1,511 | ||||
| ORAC quartile | ||||||||||||||||||||
| 1 | 20.0 | 19.2, 20.8 | 2,298 | 6,850 | 22.2 | 20.6, 24.0 | 698 | 1,705 | 25.9 | 22.4, 29.8 | 202 | 467 | 27.0 | 21.0, 34.1 | 76 | 157 | ||||
| 2 | 17.3 | 16.4, 18.1 | 1,711 | 6,729 | 19.0 | 17.5, 20.6 | 586 | 1,759 | 21.1 | 18.2, 24.3 | 194 | 555 | 22.1 | 15.9, 29.8 | 43 | 135 | ||||
| 3 | 16.9 | 16.0, 17.7 | 1,622 | 6,667 | 17.0 | 15.6, 18.5 | 538 | 1,843 | 19.0 | 16.1, 22.2 | 159 | 508 | 19.7 | 14.6, 25.9 | 51 | 161 | ||||
| 4 | 15.8 | 15.0, 16.7 | 1,316 | 6,371 | 17.3 | 15.9, 18.8 | 560 | 1,975 | 18.5 | 16.0, 21.2 | 197 | 627 | 19.5 | 15.0, 25.0 | 63 | 205 | ||||
| ORAC quartile | ||||||||||||||||||||
| 1 | 25.1 | 24.1, 26.2 | 2,180 | 5,517 | 26.7 | 25.1, 28.3 | 1,160 | 2,564 | 28.1 | 26.2, 30.1 | 833 | 1,731 | 29.7 | 27.4, 32.0 | 659 | 1,508 | ||||
| 2 | 21.8 | 20.7, 22.9 | 1,617 | 5,154 | 21.6 | 20.3, 23.1 | 943 | 2,645 | 24.1 | 22.4, 25.9 | 710 | 1,857 | 25.4 | 23.4, 27.4 | 625 | 1,664 | ||||
| 3 | 20.3 | 19.2, 21.4 | 1,361 | 4,906 | 22.2 | 20.8, 23.6 | 947 | 2,809 | 22.3 | 20.6, 24.2 | 610 | 1,904 | 23.2 | 21.3, 25.2 | 566 | 1,701 | ||||
| 4 | 19.9 | 18.7, 21.1 | 1,160 | 4,567 | 21.6 | 20.2, 23.1 | 865 | 2,785 | 20.9 | 19.2, 22.7 | 594 | 1,967 | 23.1 | 21.3, 24.9 | 648 | 2,001 | ||||
Abbreviations: CI, confidence interval; ORAC, oxygen radical absorbance capacity; PY, person-years.
a Baseline dates varied by cohort and analysis. Follow-up ended on September 30, 2015.
b Total number of participants in category.
c Because of the time-updated exposures, person-years at risk are given.
d Median ORAC value: quartile 1 (<9,546 µmol/day), 7,914 µmol/day; quartile 2 (9,546–<12,217 µmol/day), 10,892 µmol/day; quartile 3 (12,217–<15,488 µmol/day), 13,653 µmol/day; quartile 4 (≥15,488 µmol/day), 18,331 µmol/day.
e Median ORAC value: quartile 1 (<10,880 µmol/day), 8,967 µmol/day; quartile 2 (10,880–<13,881 µmol/day), 12,418 µmol/day; quartile 3 (13,881–<17,457 µmol/day), 15,477 µmol/day; quartile 4 (≥17,457 µmol/day), 20,490 µmol/day.
Figure 2.Adjusted hazard ratios (HRs) and 95% confidence intervals (in parentheses) for all-cause mortality according to combined intakes of milk and fruit and vegetables, using persons with the lowest milk intake and the highest fruit and vegetable intake as the reference group. A) HRs based on time-updated information on the whole Swedish Mammography Cohort (SMC) (women, baseline 1987–1990); B) HRs based on the SMC after administration of the second food frequency questionnaire (women, baseline 1997); C) HRs based on the Cohort of Swedish Men (men, baseline 1997). The shading corresponds to the value of the HR; the darker the shading, the larger the HR. One glass of milk corresponds to 200 mL. Covariates were age, body mass index (weight (kg)/height (m)2), height, energy intake, alcohol intake, intakes of yogurt, cheese, and red and processed meat, education, marital status (living alone vs. not), physical activity (metabolic equivalent-hours/day), smoking habits (never, former, or current smoker and, for baseline 1997, also pack-years of smoking), ever use of antioxidant-containing supplements, and weighted Charlson's comorbidity index.
Figure 3.Adjusted hazard ratios (HRs) and 95% confidence intervals (in parentheses) for all-cause mortality according to combined daily intake of milk and oxygen radical absorbance capacity (ORAC; µmol/day), using persons with the lowest intake of milk and the highest quartile of ORAC as the reference group. A) HRs based on the Swedish Mammography Cohort after administration of the second food frequency questionnaire (women, baseline 1997); B) HRs based on the Cohort of Swedish Men (men, baseline 1997). The shading corresponds to the value of the HR; the darker the shading, the larger the HR. One glass of milk corresponds to 200 mL. Covariates were age, body mass index (weight (kg)/height (m)2), height, energy intake, alcohol intake, intakes of yogurt, cheese, and red and processed meat, education, marital status (living alone vs. not), physical activity (metabolic equivalent-hours/day), smoking habits (never, former, or current smoker and pack-years of smoking), ever use of antioxidant-containing supplements, and weighted Charlson's comorbidity index.
Figure 4.Overview of galactose metabolism. The major pathway of galactose metabolism (the Leloir pathway) operates via the enzymes galactokinase (GALK), galactose-1-phosphate uridylyltransferase (GALT), and uridine diphosphate (UDP) galactose 4-epimerase (GALE), resulting in UDP-glucose. The conversion to galactitol by aldose reductase via the polyol pathway results in decreased availability of nicotinamide adenine dinucleotide phosphate (NADPH) and glutathione, with increased production of free radicals (56). By way of a nonenzymatic reaction with amino groups in proteins, lipids, and nucleic acids, galactose is converted to advanced glycation end products (AGEs).